(Q47436803)

16 January 2018

title

CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy. (English)

1 reference

16 January 2018

enzyme replacement therapy

main subject

0 references

1 reference

7

U Matte

1 reference

16 January 2018

Roberto Giugliani

11

R Giugliani

1 reference

16 January 2018

Ida Vanessa D Schwartz

3

I V D Schwartz

1 reference

16 January 2018

Laura Bannach Jardim

1

L Jardim

1 reference

16 January 2018

Maira Graeff Burin

4

M G Burin

1 reference

16 January 2018

author name string

L Vedolin

2

1 reference

16 January 2018

C Cecchin

5

1 reference

16 January 2018

L Kalakun

6

1 reference

16 January 2018

F Aesse

8

1 reference

16 January 2018

C Pitta-Pinheiro

9

1 reference

16 January 2018

J Marconato

10

1 reference

16 January 2018

publication date

1 January 2004

1 reference

16 January 2018

Journal of Inherited Metabolic Disease

published in

1 reference

16 January 2018

volume

27

1 reference

16 January 2018

issue

2

1 reference

16 January 2018

page(s)

229-240

1 reference

16 January 2018

https://scigraph.springernature.com/pub.10.1023/b:boli.0000028794.04349.91

exact match

0 references

cites work

Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study

1 reference

12 December 2020

Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients.

1 reference

12 December 2020

Anderson-Fabry disease: extrarenal, neurologic manifestations

1 reference

12 December 2020

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

1 reference

12 December 2020

Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy

1 reference

12 December 2020

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

1 reference

12 December 2020

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

1 reference

12 December 2020

Proton MR spectroscopy of polymicrogyria and heterotopia.

1 reference

12 December 2020

Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease

1 reference

12 December 2020

Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T

1 reference

12 December 2020

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

1 reference

12 December 2020

Natural history of Fabry disease in males: preliminary observations.

1 reference

12 December 2020

Fabry disease: comparison of enzymatic, linkage, and mutation analysis for carrier detection in a family with a novel mutation (30delG)

1 reference

12 December 2020

Cerebrovascular complications of Fabry's disease

1 reference

12 December 2020

Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement.

1 reference

12 December 2020

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

1 reference

12 December 2020

Quantitative analysis of cerebral vasculopathy in patients with Fabry disease.

1 reference

12 December 2020

10.1023/B:BOLI.0000028794.04349.91

Identifiers

DOI

1 reference

16 January 2018

Dimensions Publication ID

0 references

1 reference

16 January 2018